4 min read
Cleerly: February 13, 2023
Heart disease is the cause of death for 700,000 Americans1 and nearly 17.9 million people worldwide every year.2 While some of these individuals...
2 min read
Cleerly: January 10, 2023
Cleerly makes early detection of heart disease risk possible through our AI-enabled analysis of coronary computed tomography angiography (CCTA)...
3 min read
Cleerly: November 9, 2022
Cleerly’s Medical Affairs team had the opportunity to present at the American Heart Association’s (AHA) 2022 Scientific Sessions this past week in...
3 min read
Cleerly: October 18, 2022
Half of patients who have a heart attack don't show symptoms prior to their event. A new standard of precision care that emphasizes comprehensive...
3 min read
James K. Min, MD, FACC, FESC, MSCCT, Founder & CEO of Cleerly: September 19, 2022
Myocardial perfusion, also known as a "stress test", is today's go-to-method for detecting coronary artery disease - despite limited performance.
3 min read
Last week, our team at Cleerly had the opportunity to take part in a gathering of impassioned cardiac computed tomography (CT) leaders at the Society...
Cleerly: June 17, 2022
Cleerly Episode Featured on the AHA's Advancing Health Podcast Series Dr. Leon D. Caldwell, Senior Director, Health Equity Strategies and Innovation,...
3 min read
Cleerly: June 8, 2022
Half of patients who have a heart attack don't show symptoms prior to their event. A new standard of precision care, emphasizing comprehensive...
2 min read
James K. Min, MD, FACC, FESC, MSCCT, Founder & CEO of Cleerly: April 15, 2022
New research proposes a four-stage system for measuring the progression of cardiovascular disease (CAD) based on atherosclerotic plaque - not...
4 min read
Cleerly is excited to have released our vision statement calling for a new approach to cardiovascular care. It's an important topic - not just for...